Cosmo Bio Company,Limited (TYO:3386)
Japan · Delayed Price · Currency is JPY 1,243.00
0.00 (0.00%)
Sep 15, 2026, 3:10 PM JST
Cosmo Bio Company,Limited Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 542 | 504 | 369 | 653 | 790 | 1,099 |
Depreciation & Amortization | 188 | 167 | 136 | 148 | 141 | 166 |
Loss (Gain) From Sale of Assets | 61 | 58 | 1 | - | - | - |
Loss (Gain) From Sale of Investments | -110 | -69 | -5 | - | - | - |
Other Operating Activities | -193 | -57 | -194 | -186 | -280 | -384 |
Change in Accounts Receivable | 42 | -83 | -140 | -40 | -73 | 75 |
Change in Inventory | -7 | -48 | -25 | 97 | -267 | -245 |
Change in Accounts Payable | 83 | 144 | 73 | 50 | -22 | -12 |
Change in Other Net Operating Assets | 13 | -21 | 26 | 14 | -5 | -51 |
Operating Cash Flow | 619 | 595 | 241 | 736 | 284 | 648 |
Operating Cash Flow Growth | -0.96% | 146.89% | -67.25% | 159.16% | -56.17% | -19.30% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -311 | -229 | -216 | -67 | -55 | -31 |
Sale (Purchase) of Intangibles | -33 | -52 | -60 | -33 | -49 | -110 |
Investment in Securities | 520 | 361 | 103 | -700 | -202 | - |
Other Investing Activities | -28 | -37 | -44 | 42 | 15 | -4 |
Investing Cash Flow | 148 | 43 | -217 | -758 | -291 | -145 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Repurchase of Common Stock | - | 69 | -299 | - | - | -194 |
Common Dividends Paid | -283 | -348 | -175 | -197 | -232 | -223 |
Other Financing Activities | -5 | -4 | -5 | -4 | -4 | -3 |
Financing Cash Flow | -219 | -283 | -479 | -201 | -236 | -420 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 25 | -1 | 22 | 13 | 24 | 12 |
Miscellaneous Cash Flow Adjustments | 1 | - | - | - | 1 | - |
Net Cash Flow | 574 | 354 | -433 | -210 | -218 | 95 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 308 | 366 | 25 | 669 | 229 | 617 |
Free Cash Flow Growth | -28.37% | 1364.00% | -96.26% | 192.14% | -62.89% | -19.56% |
Free Cash Flow Margin | 2.73% | 3.40% | 0.25% | 7.16% | 2.40% | 6.68% |
Free Cash Flow Per Share | 54.24 | 64.36 | 4.30 | 114.78 | 39.45 | 106.22 |
Levered Free Cash Flow | 167.5 | 397.38 | -356.63 | 481.63 | 147.63 | 290.25 |
Unlevered Free Cash Flow | 167.5 | 397.38 | -356.63 | 481.63 | 147.63 | 290.25 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 191 | 57 | 193 | 185 | 279 | 385 |
Change in Working Capital | 131 | -8 | -66 | 121 | -367 | -233 |